Journal article
Heterogeneity of associations between total and types of fish intake and the incidence of type 2 diabetes: Federated meta-analysis of 28 prospective studies including 956,122 participants
S Pastorino, T Bishop, SJ Sharp, M Pearce, T Akbaraly, NB Barbieri, M Bes-Rastrollo, JWJ Beulens, Z Chen, H Du, BB Duncan, A Goto, T Härkänen, M Hashemian, D Kromhout, R Järvinen, M Kivimaki, P Knekt, X Lin, E Lund Show all
Nutrients | MDPI | Published : 2021
DOI: 10.3390/nu13041223
Abstract
The association between fish consumption and new-onset type 2 diabetes is inconsistent and differs according to geographical location. We examined the association between the total and types of fish consumption and type 2 diabetes using individual participant data from 28 prospective cohort studies from the Americas (6), Europe (15), the Western Pacific (6), and the Eastern Mediterranean (1) comprising 956,122 participants and 48,084 cases of incident type 2 diabetes. Incidence rate ratios (IRRs) for associations of total fish, shellfish, fatty, lean, fried, freshwater, and saltwater fish intake and type 2 diabetes were derived for each study, adjusting for a consistent set of con-founders a..
View full abstractGrants
Awarded by European Commission
Funding Acknowledgements
The InterConnect project is funded by the European Union's Seventh Framework Programme (grant number 602068). NJW, NGF, SP, and MP acknowledge funding from the Medical Research Council Epidemiology Unit (MC_UU_00006/1 and MC_UU_00006/3); NJW and NGF acknowledge support from NIHR Biomedical Research Centre Cambridge: Nutrition, Diet, and Lifestyle Research Theme (IS-BRC-1215-20014). TB acknowledges funding from EUCAN-Connect under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 824989). Australian Diabetes, Obesity and Lifestyle Study (AusDiab): National Health and Medical Research Council (NHMRC grants 233200 and 1007544), Australian Government Department of Health and Ageing, Abbott Australasia Pty Ltd., Alphapharm Pty Ltd., Amgen Australia, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service-Canberra, Department of Health and Community Services-Northern Territory, Department of Health and Human ServicesTasmania, Department of Health-New South Wales, Department of Health-Western Australia, Department of Health-South Australia, Department of Human Services-Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late EdwardWilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian & FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd., Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis, sanofi-synthelabo, and the Victorian Government's OIS Program. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): ELSABrasil was supported by the Brazilian Ministry of Health (Department of Science and Technology) and Ministry of Science, Technology and Innovation (Financiadora de Estudos e Projetos-FINEP, grant numbers 01 06 0010.00, 01 06 0212.00, 01 06 0300.00, 01 06 0278.00, 01 06 0115.00 and 01 06 0071.00 and the National Council for Scientific and Technological Development-CNPq. The Cohort of Swedish Men (COSM) and the Swedish Mammography Cohort (SMC) are part of the national infrastructure SIMPLER, which receives funding from the Swedish Research Council (2017-00644). Golestan study: Tehran University of Medical Sciences [grant No: 81/15]; Cancer Research UK [grant No: C20/A5860]; the Intramural Research Program of the NCI, National Institutes of Health; and various collaborative research agreements with IARC. Hoorn study: Funding for the Hoorn Study was provided by several different sponsors, including: the VU University Medical Center of Amsterdam, the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMW), the Dutch Diabetes Research Foundation, and the Netherlands Heart Foundation. Funding for the New Hoorn Study was provided by: the VU University Medical Center of Amsterdam, Novartis Pharma B.V, the European Union, and the Innovative Medicine Initiative. The JPHC study was supported by the National Cancer Center Research and Development Fund (23-A-31 [toku], 26-A-2, 29-A-4) (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour andWelfare of Japan (from 1989 to 2010). Nutrition and Health of Aging Population of China (NHAPC) Study: the Ministry of Science and Technology of China (2017YFC0909700), the National Natural Science Foundation of China (30930081, 81321062, 81970684, 81700700). Seguimiento Universidad de Navarra (SUN): The SUN Project has received funding from the Spanish Government-Instituto de Salud Carlos III, and the European Regional Development Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795, and G03/140), the Navarra Regional Government (27/2011, 45/2011, 122/2014), and the University of funding.